Serhat Özkan

502 total citations
26 papers, 327 citations indexed

About

Serhat Özkan is a scholar working on Neurology, Surgery and Psychiatry and Mental health. According to data from OpenAlex, Serhat Özkan has authored 26 papers receiving a total of 327 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Neurology, 8 papers in Surgery and 7 papers in Psychiatry and Mental health. Recurrent topics in Serhat Özkan's work include Dementia and Cognitive Impairment Research (5 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Alzheimer's disease research and treatments (3 papers). Serhat Özkan is often cited by papers focused on Dementia and Cognitive Impairment Research (5 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Alzheimer's disease research and treatments (3 papers). Serhat Özkan collaborates with scholars based in Türkiye, United States and United Kingdom. Serhat Özkan's co-authors include Nevbahar Akçar, Baki Adapınar, Funda Taşçıoğlu, Cüneyt Çalışır, Alı Arslantaş, Özkan Alataş, Ömer Çolak, Selma Metintaş, Cemalettin Kalyoncu and Didem Arslantaş and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Neuroscience Letters.

In The Last Decade

Serhat Özkan

21 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Serhat Özkan Türkiye 10 99 94 63 58 56 26 327
Min-Chien Tu Taiwan 12 108 1.1× 60 0.6× 44 0.7× 32 0.6× 155 2.8× 30 419
Yasuko Tatewaki Japan 13 98 1.0× 41 0.4× 62 1.0× 34 0.6× 36 0.6× 52 427
Serpil Demirci Türkiye 14 180 1.8× 142 1.5× 65 1.0× 77 1.3× 129 2.3× 42 585
Carlos Romero Argentina 11 82 0.8× 42 0.4× 103 1.6× 58 1.0× 52 0.9× 30 411
Feiwen Liu China 9 38 0.4× 57 0.6× 48 0.8× 35 0.6× 54 1.0× 17 423
Nofal Khalil United Kingdom 11 53 0.5× 130 1.4× 46 0.7× 49 0.8× 75 1.3× 13 325
Ahmet Tüfekçi Türkiye 10 131 1.3× 43 0.5× 67 1.1× 42 0.7× 114 2.0× 22 473
Matthew A Rouse United Kingdom 12 52 0.5× 26 0.3× 95 1.5× 40 0.7× 135 2.4× 37 473
Leslie Sedal Australia 10 64 0.6× 52 0.6× 31 0.5× 32 0.6× 55 1.0× 18 322
Gülşen Kocaman Türkiye 10 32 0.3× 39 0.4× 39 0.6× 33 0.6× 106 1.9× 24 298

Countries citing papers authored by Serhat Özkan

Since Specialization
Citations

This map shows the geographic impact of Serhat Özkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serhat Özkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serhat Özkan more than expected).

Fields of papers citing papers by Serhat Özkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serhat Özkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serhat Özkan. The network helps show where Serhat Özkan may publish in the future.

Co-authorship network of co-authors of Serhat Özkan

This figure shows the co-authorship network connecting the top 25 collaborators of Serhat Özkan. A scholar is included among the top collaborators of Serhat Özkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serhat Özkan. Serhat Özkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toprak, Uğur, et al.. (2024). Evaluation of Substantia Nigra morphology in Parkinson’s Disease. Medicine. 103(12). e37538–e37538.
2.
Özben, Serkan, et al.. (2023). A novel mutation in RNF216 gene in a Turkish case with Gordon Holmes syndrome. BMC Medical Genomics. 16(1). 98–98. 2 indexed citations
3.
Samancı, Bedia, et al.. (2022). HOW THE FREQUENCY OF PAIN IN THE EARLY STAGES OF PARKINSON’S DISEASE AFFECTS THE SPEED OF DIAGNOSIS. SHILAP Revista de lepidopterología. 85(2). 155–161. 1 indexed citations
4.
Özkan, Serhat, et al.. (2022). Yenidoğanlarda Persistan Pulmoner Hipertansiyon Risk Faktörleri, Klinik ve Prognozun Belirlenmesi. SHILAP Revista de lepidopterología. 22(2). 110–116.
5.
Hişmi, Burcu Öztürk, et al.. (2021). Patients with cerebrotendinous xanthomatosis diagnosed with diverse multisystem involvement. Metabolic Brain Disease. 36(6). 1201–1211. 8 indexed citations
6.
Özkan, Serhat, et al.. (2021). Patient Communication and Consultation Experience with Telemedicine in Patients with Movement Dısorders in COVID-19 Pandemic: Its Usability, Benefits and Problems. SHILAP Revista de lepidopterología. 27(1(supple)). 9–14. 1 indexed citations
7.
Tosun, Zeynep, et al.. (2020). THE VALIDITY AND RELIABILITY OF THE TURKISH FORM OF THE SCOPA SLEEP SCALE IN PARKINSON’S DISEASE. Nöro Psikiyatri Arşivi. 59(1). 33–37. 3 indexed citations
8.
Kaymak, Bayram, et al.. (2018). Ultrasound-Guided Botulinum Toxin Injections in Cervical Dystonia Needs Prompt Muscle Selection, Appropriate Dosage and Precise Guidance. American Journal of Physical Medicine & Rehabilitation. 1–1.
9.
Çilingir, Oğuz, et al.. (2017). Association of functional RAGE gene polymorphisms with Parkinson's disease in a Turkish cohort. Biomedical Research-tokyo. 28(19). 8454–8460. 1 indexed citations
10.
Özkan, Serhat, et al.. (2015). Is the 1254T>C polymorphism in the DMT1 gene associated with Parkinson’s disease?. Neuroscience Letters. 594. 51–54. 12 indexed citations
11.
Çarman, Kürşat Bora, et al.. (2013). Essential Palatal Tremor Treated With Botulinum Toxin. Pediatric Neurology. 48(5). 415–417. 6 indexed citations
12.
Özkan, Serhat, et al.. (2013). Apraxia for differentiating Alzheimer’s disease from subcortical vascular dementia and mild cognitive impairment. Neuropsychiatric Disease and Treatment. 9. 947–947. 19 indexed citations
13.
Çarman, Kürşat Bora, et al.. (2013). Marcus Gunn jaw winking synkinesis: report of two cases. BMJ Case Reports. 2013. bcr2012008210–bcr2012008210. 7 indexed citations
14.
Uslu, Sema, et al.. (2012). Levels of Amyloid Beta-42, Interleukin-6 and Tumor Necrosis Factor-Alpha in Alzheimer’s Disease and Vascular Dementia. Neurochemical Research. 37(7). 1554–1559. 56 indexed citations
15.
Taşçıoğlu, Funda, et al.. (2010). Low-level laser in the treatment of carpal tunnel syndrome: clinical, electrophysiological, and ultrasonographical evaluation. Rheumatology International. 32(2). 409–415. 44 indexed citations
16.
Yenilmez, Çınar, et al.. (2010). An Analysis of Changes in Cerebral Blood Flood Velocities in Depressive Pseudo-Dementia and Alzheimer Disease Patients. The Neurologist. 16(6). 358–363. 12 indexed citations
17.
Arslantaş, Didem, et al.. (2009). Prevalence of dementia and associated risk factors in Middle Anatolia, Turkey. Journal of Clinical Neuroscience. 16(11). 1455–1459. 47 indexed citations
18.
Özkan, Serhat, et al.. (2006). The effect of methylprednisolone treatment on cerebral reactivity in patients with multiple sclerosis. Journal of Clinical Neuroscience. 13(2). 214–217. 14 indexed citations
19.
Özkan, Serhat, et al.. (2005). Does radial artery harvesting for coronary revascularization cause neurological injury in the forearm and hand?. European Journal of Cardio-Thoracic Surgery. 28(3). 420–424. 14 indexed citations
20.
Özkan, Serhat, et al.. (2004). Plasma Homocysteine Levels in Pergolide-Treated Parkinson Disease Patients. Clinical Neuropharmacology. 27(4). 163–165. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Min-Chien Tu Breakdown of academic impact, for papers by Yasuko Tatewaki Breakdown of academic impact, for papers by Serpil Demirci Breakdown of academic impact, for papers by Carlos Romero Breakdown of academic impact, for papers by Feiwen Liu Breakdown of academic impact, for papers by Nofal Khalil Breakdown of academic impact, for papers by Ahmet Tüfekçi Breakdown of academic impact, for papers by Matthew A Rouse Breakdown of academic impact, for papers by Leslie Sedal Breakdown of academic impact, for papers by Gülşen Kocaman
Rankless by CCL
2026